SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2013. The put-call ratio across all filers is 0.12 and the average weighting 1.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,058,136 | $71,893,000 | 85.78% |
| ARMISTICE CAPITAL, LLC | 3,240,000 | $6,286,000 | 2.79% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 738,748 | $1,433,000 | 0.26% |
| Geller Advisors LLC | 187,323 | $363,000 | 0.21% |
| Verity Asset Management, Inc. | 56,518 | $110,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 334,713 | $649,000 | 0.08% |
| Cutler Capital Management, LLC | 72,500 | $140,000 | 0.06% |
| BLUE ARROW CAPITAL MANAGEMENT LLC | 199,930 | $388,000 | 0.04% |
| Jefferies Group LLC | 3,240,000 | $6,286,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 399,000 | $794,000 | 0.03% |